{"id":"saline-serum","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperchloremic acidosis"},{"rate":null,"effect":"Fluid overload / pulmonary edema"},{"rate":null,"effect":"Hypernatremia"},{"rate":null,"effect":"Phlebitis at injection site"}]},"_chembl":{"chemblId":"CHEMBL2109149","moleculeType":"Protein"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=saline serum","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T05:22:33.284121+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T05:22:39.429351+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=saline serum","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T05:22:39.701523+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2109149/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:22:40.402554+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Saline serum provides essential sodium and chloride ions in physiological concentrations to maintain osmotic balance and hydration status. It is used to replace lost fluids, maintain vascular volume, and support cellular function during dehydration or blood loss. The solution mimics the electrolyte composition of blood plasma to prevent osmotic complications.","oneSentence":"Saline serum is an isotonic sodium chloride solution that restores fluid and electrolyte balance in the body.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:06:37.420Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:22:41.971744+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Fluid and electrolyte replacement in dehydration"},{"name":"Maintenance of vascular volume during surgery or trauma"},{"name":"Vehicle for intravenous medication administration"}]},"trialDetails":[{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT03844061","phase":"PHASE2","title":"Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis","status":"RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2019-07-29","conditions":"Systemic Sclerosis","enrollment":30},{"nctId":"NCT04751175","phase":"PHASE4","title":"Management of Pain in Lumbar Arthrodesis","status":"COMPLETED","sponsor":"Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta","startDate":"2013-07-04","conditions":"Pain, Postoperative","enrollment":128},{"nctId":"NCT06926478","phase":"PHASE1","title":"Subconjunctival Humira for Boston Keratoprosthesis","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2026-06-01","conditions":"Penetrating Keratoplasty, Multiple Graft Failure, Ocular Cicatricial Pemphigoid","enrollment":8},{"nctId":"NCT07490808","phase":"NA","title":"Peri-procedural Hydration to Prevent Acute Kidney Injury After Pulsed Field Ablation for Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2026-03","conditions":"Atrial Fibrillation (AF), Acute Kidney Injury","enrollment":290},{"nctId":"NCT04641351","phase":"PHASE4","title":"Corticosteroid Meniscectomy Randomized Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2021-05-27","conditions":"Osteoarthritis, Knee, Meniscus Tear, Meniscus; Degeneration","enrollment":150},{"nctId":"NCT01011920","phase":"PHASE2","title":"Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma","status":"COMPLETED","sponsor":"International Extranodal Lymphoma Study Group (IELSG)","startDate":"2009-11","conditions":"Central Nervous System Lymphoma","enrollment":227},{"nctId":"NCT03418038","phase":"PHASE2","title":"Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-03-23","conditions":"Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Diffuse Large B-Cell Lymphoma","enrollment":80},{"nctId":"NCT06599307","phase":"PHASE2","title":"The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis","status":"RECRUITING","sponsor":"Cairo University","startDate":"2024-08-01","conditions":"Secondary Progressive Multiple Sclerosis (SPMS)","enrollment":46},{"nctId":"NCT05701189","phase":"PHASE2","title":"Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome","status":"WITHDRAWN","sponsor":"Chafic Karam","startDate":"2024-09-10","conditions":"Guillain-Barre Syndrome","enrollment":""},{"nctId":"NCT04862221","phase":"PHASE2","title":"TReatment for ImmUne Mediated PathopHysiology","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2022-02-09","conditions":"Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy","enrollment":163},{"nctId":"NCT07460908","phase":"NA","title":"Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome","status":"COMPLETED","sponsor":"Lahore General Hospital","startDate":"2025-05-01","conditions":"Hepatorenal Syndrome","enrollment":60},{"nctId":"NCT05116189","phase":"PHASE3","title":"Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-12-13","conditions":"Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms","enrollment":643},{"nctId":"NCT06534983","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2024-12-09","conditions":"Muscle-invasive Urothelial Carcinoma","enrollment":362},{"nctId":"NCT03847428","phase":"PHASE3","title":"Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2019-04-29","conditions":"Hepatocellular Carcinoma","enrollment":908},{"nctId":"NCT05350774","phase":"PHASE2","title":"Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2023-07-10","conditions":"Systemic Inflammation, Neuroinflammation, Microvascular Thrombosis","enrollment":45},{"nctId":"NCT04608630","phase":"PHASE2","title":"Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults","status":"RECRUITING","sponsor":"Australian and New Zealand Intensive Care Research Centre","startDate":"2021-07-15","conditions":"Critical Illness, Osteoporosis","enrollment":450},{"nctId":"NCT07246863","phase":"PHASE2","title":"Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC","status":"RECRUITING","sponsor":"CatalYm GmbH","startDate":"2025-10-07","conditions":"Metastatic Non-Squamous Non-Small Cell Lung Cancer, Adult Solid Tumor","enrollment":131},{"nctId":"NCT07449364","phase":"NA","title":"Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient","status":"COMPLETED","sponsor":"Daewoong Group Indonesia","startDate":"2025-03-24","conditions":"Frailty in Older Adults","enrollment":10},{"nctId":"NCT05832034","phase":"PHASE2, PHASE3","title":"Add-on Intravenous Immunoglobulins in Early Myositis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-09-13","conditions":"Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome","enrollment":44},{"nctId":"NCT04610671","phase":"PHASE1","title":"Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2020-10-26","conditions":"Muscle-Invasive Bladder Carcinoma, Bladder Cancer","enrollment":21},{"nctId":"NCT06797375","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants","status":"COMPLETED","sponsor":"Rallybio","startDate":"2025-04-14","conditions":"Hematologic Diseases, Autoimmune Diseases","enrollment":16},{"nctId":"NCT04066348","phase":"PHASE2","title":"TNF-α Treatment of Blast-Induced Tinnitus","status":"RECRUITING","sponsor":"Wayne State University","startDate":"2022-07-01","conditions":"Tinnitus, Noise Induced","enrollment":88},{"nctId":"NCT05864118","phase":"NA","title":"Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses","status":"RECRUITING","sponsor":"University of Nebraska","startDate":"2023-08-21","conditions":"Respiratory Tract Infections","enrollment":1000},{"nctId":"NCT05440851","phase":"NA","title":"Platform of Randomized Adaptive Clinical Trials in Critical Illness","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2023-04-30","conditions":"Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High","enrollment":6250},{"nctId":"NCT06305780","phase":"PHASE2","title":"RECOVER-AUTONOMIC Platform Protocol","status":"COMPLETED","sponsor":"Kanecia Obie Zimmerman","startDate":"2024-03-11","conditions":"Long COVID, Long Covid19, Long Covid-19","enrollment":381},{"nctId":"NCT05781295","phase":"NA","title":"Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric Oncology","status":"RECRUITING","sponsor":"Institut Curie","startDate":"2024-01-19","conditions":"Children, Medical Device, Primary Prevention","enrollment":148},{"nctId":"NCT03929601","phase":"PHASE2","title":"Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2023-10-30","conditions":"Type 1 Diabetes Mellitus","enrollment":74},{"nctId":"NCT04380740","phase":"PHASE2","title":"Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2022-03-30","conditions":"Graft Vs Host Disease","enrollment":160},{"nctId":"NCT07418580","phase":"NA","title":"Magnesium Sulfate Infusion on Postoperative Pain in Lumbar Surgery","status":"COMPLETED","sponsor":"Sisli Hamidiye Etfal Training and Research Hospital","startDate":"2021-04-01","conditions":"Postoperative Pain, Back Pain Lower Back Chronic","enrollment":60},{"nctId":"NCT03295383","phase":"PHASE3","title":"Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2019-07-11","conditions":"Severe Forms of Mucous Membrane Pemphigoid","enrollment":130},{"nctId":"NCT07059091","phase":"PHASE2","title":"Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-02-12","conditions":"Chronic Obstructive Pulmonary Disease (COPD), Allergies","enrollment":334},{"nctId":"NCT07415655","phase":"PHASE2","title":"Modulation of Cerebral Ischemia by Albumin","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Hradec Kralove","startDate":"2026-02-03","conditions":"Ischemic Stroke","enrollment":100},{"nctId":"NCT07413172","phase":"PHASE2","title":"Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-03","conditions":"Dry Eye, Eye Diseases, Eyes Dry Chronic","enrollment":20},{"nctId":"NCT07409051","phase":"","title":"Persistence of Sensitization to Contrast Media","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2026-02","conditions":"Contrast Media Allergy","enrollment":100},{"nctId":"NCT02743455","phase":"PHASE1","title":"A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-07-05","conditions":"Yellow Fever, Yellow Fever Immunisation","enrollment":92},{"nctId":"NCT01237054","phase":"PHASE2","title":"Imaging in MGUS, SMM and MM","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2010-10-17","conditions":"Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance","enrollment":31},{"nctId":"NCT05533164","phase":"PHASE3","title":"Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Experiencing a PMR Relapse","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sint Maartenskliniek","startDate":"2023-02-09","conditions":"Polymyalgia Rheumatica","enrollment":174},{"nctId":"NCT03635567","phase":"PHASE3","title":"Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-10-25","conditions":"Cervical Cancer","enrollment":617},{"nctId":"NCT05857371","phase":"PHASE2","title":"Safety and Potential Effect of Innovative Treatment by Adjuvant Injection of Stromal Vascular Fraction From Autologous Adipose Tissue of URethral Stenosis With Endoscopic Urethrotomy","status":"RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2024-03-13","conditions":"Urethral Stenosis","enrollment":20},{"nctId":"NCT07386938","phase":"PHASE3","title":"A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"R-Pharm","startDate":"2024-08-09","conditions":"Locally Advanced Breast Cancer, Metastatic Breast Cancer","enrollment":246},{"nctId":"NCT05533125","phase":"PHASE3","title":"Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently Diagnosed","status":"COMPLETED","sponsor":"Sint Maartenskliniek","startDate":"2023-02-01","conditions":"Polymyalgia Rheumatica","enrollment":114},{"nctId":"NCT05056220","phase":"PHASE3","title":"Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites","status":"RECRUITING","sponsor":"Aleksander Krag","startDate":"2024-02-26","conditions":"Decompensated Cirrhosis and Ascites","enrollment":240},{"nctId":"NCT03951519","phase":"NA","title":"Effect of Oral Water on the Quality of Volume Expansion in Resuscitation Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2019-05-24","conditions":"Intubated-ventilated Patients in the Intensive Care Unit","enrollment":50},{"nctId":"NCT03594487","phase":"PHASE1","title":"Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis","status":"TERMINATED","sponsor":"Jeffrey Gelfand","startDate":"2018-11-16","conditions":"Relapsing Remitting Multiple Sclerosis","enrollment":5},{"nctId":"NCT03153319","phase":"PHASE1, PHASE2","title":"Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2017-06-05","conditions":"Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI","enrollment":14},{"nctId":"NCT07371624","phase":"PHASE1, PHASE2","title":"A Study of the Safety, Tolerability and Preliminary Efficacy of B2065 in Patients With Acute Ischemic Stroke.","status":"RECRUITING","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2025-12-31","conditions":"Acute Ischemic Stroke","enrollment":54},{"nctId":"NCT06264531","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous Malformations","status":"RECRUITING","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2026-01-16","conditions":"Cerebral AV Malformation","enrollment":54},{"nctId":"NCT05331872","phase":"PHASE1","title":"Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2021-01-01","conditions":"Liver Cirrhosis","enrollment":20},{"nctId":"NCT07350135","phase":"NA","title":"Sodium Supplementation and Growth in Premature Neonates","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ain Shams University","startDate":"2025-11-06","conditions":"Sodium Supplementation and Growth in Premature Neonates","enrollment":74},{"nctId":"NCT07352241","phase":"NA","title":"Repeated Injections of i-PRF for Decreasing Root Resorption After the Orthodontic Treatment.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2024-01-13","conditions":"Crowding of Anterior Maxillary Teeth","enrollment":36},{"nctId":"NCT03778957","phase":"PHASE3","title":"A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2018-11-30","conditions":"Hepatocellular Carcinoma","enrollment":724},{"nctId":"NCT02807103","phase":"PHASE3","title":"Rituximab in Eosinophilic Granulomatosis With Polyangiitis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-12-05","conditions":"Eosinophilic Granulomatosis With Polyangiitis (EGPA)","enrollment":107},{"nctId":"NCT06569862","phase":"NA","title":"Comparison of the Risk of Surgical Site Infections Between Dressings Stopped at Postoperative Day 1 vs Dressings Stopped at Postoperative Day 6+/-1 After Elective Abdominal Surgery","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-11-06","conditions":"Elective Abdominal Surgery","enrollment":1288},{"nctId":"NCT04361474","phase":"PHASE3","title":"Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity","status":"COMPLETED","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2020-05-18","conditions":"Budesonide, Olfaction Disorders, SARS-CoV-2","enrollment":120},{"nctId":"NCT05428007","phase":"PHASE2","title":"Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2023-02-02","conditions":"Melanoma, Unresectable Melanoma","enrollment":105},{"nctId":"NCT02990286","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2017-01-20","conditions":"Lung Disease, Interstitial","enrollment":122},{"nctId":"NCT01350882","phase":"PHASE3","title":"Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2008-10","conditions":"Humoral Rejection in Kidney Transplantation","enrollment":40},{"nctId":"NCT01757418","phase":"PHASE1, PHASE2","title":"Intravenous Gammaglobulin for Sickle Cell Pain Crises","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2008-11","conditions":"Sickle Cell Disease, Pain","enrollment":300},{"nctId":"NCT03362242","phase":"PHASE1","title":"Study of ARO-AAT in Normal Adult Volunteers","status":"COMPLETED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2018-03-12","conditions":"Alpha 1-Antitrypsin Deficiency","enrollment":45},{"nctId":"NCT05742243","phase":"PHASE2","title":"Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes","status":"COMPLETED","sponsor":"Melbourne Health","startDate":"2023-02-13","conditions":"Type 1 Diabetes, Diabetes Mellitus, Type 1","enrollment":68},{"nctId":"NCT05187429","phase":"PHASE1, PHASE2","title":"Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy","status":"RECRUITING","sponsor":"University of Melbourne","startDate":"2023-01-24","conditions":"HIV I Infection","enrollment":42},{"nctId":"NCT06300229","phase":"PHASE1, PHASE2","title":"NAPO - Novel Approach for Oligospermia","status":"COMPLETED","sponsor":"Martin Blomberg Jensen","startDate":"2024-03-01","conditions":"Infertility, Male","enrollment":42},{"nctId":"NCT07288827","phase":"NA","title":"Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia","status":"RECRUITING","sponsor":"Indiana University","startDate":"2023-05-04","conditions":"Primary Ciliary Dyskinesia, Healthy","enrollment":40},{"nctId":"NCT05645107","phase":"PHASE3","title":"A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma","status":"RECRUITING","sponsor":"Grifols Therapeutics LLC","startDate":"2022-12-26","conditions":"Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia","enrollment":386},{"nctId":"NCT07271771","phase":"PHASE4","title":"The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2024-05-21","conditions":"Osteoporosis","enrollment":40},{"nctId":"NCT06654063","phase":"NA","title":"Clinical Assessment of Adjunctive Omega-3 Versus Vitamin D Daily Supplements on Active Periodontal Therapy With Stage II Grade B Periodontitis Patients","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-04-01","conditions":"Vitamin D Deficiency","enrollment":72},{"nctId":"NCT06356025","phase":"PHASE4","title":"Botulinum Toxin Injection in the UES for R-CPD","status":"ACTIVE_NOT_RECRUITING","sponsor":"AZ Delta","startDate":"2024-09-02","conditions":"Retrograde Cricopharyngeus Dysfunction","enrollment":50},{"nctId":"NCT07083063","phase":"PHASE4","title":"Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis","status":"RECRUITING","sponsor":"National Cheng-Kung University Hospital","startDate":"2025-09-15","conditions":"Pancreatitis","enrollment":440},{"nctId":"NCT06527235","phase":"PHASE3","title":"Meniscal INfiltration of Corticosteroid Guided With Ultra Sonography","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-03-06","conditions":"Meniscus Lesion","enrollment":152},{"nctId":"NCT06390956","phase":"PHASE2","title":"Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)","status":"RECRUITING","sponsor":"University of Utah","startDate":"2025-02-20","conditions":"Marginal Zone Lymphoma","enrollment":23},{"nctId":"NCT07256613","phase":"NA","title":"Non-surgical Periodontal Therapy and Kidney Outcomes in Type 2 Diabetes Mellitus","status":"RECRUITING","sponsor":"Dow University of Health Sciences","startDate":"2025-08-15","conditions":"Type 2 Diabetes Mellitus MeSH:D003924, Periodontitis MeSH:D010518, Diabetic Nephropathies MeSH:D003928","enrollment":46},{"nctId":"NCT07073846","phase":"PHASE4","title":"Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.","status":"RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-10-06","conditions":"Morbid Obesity Requiring Bariatric Surgery, Postoperative Pain, Postoperative Pain Management","enrollment":104},{"nctId":"NCT07252505","phase":"EARLY_PHASE1","title":"Early Intravenous Magnesium Sulfate and Its Impact on Cerebral Vasospasm in Traumatic Subarachnoid Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-11","conditions":"Trauma and Emergency Care","enrollment":50},{"nctId":"NCT06455319","phase":"PHASE2","title":"Precision Administration of Anti-thymocyte Globulin With or Without Verapamil","status":"RECRUITING","sponsor":"University of Florida","startDate":"2025-11-12","conditions":"Type 1 Diabetes","enrollment":60},{"nctId":"NCT05136976","phase":"PHASE3","title":"Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2023-06-29","conditions":"Anti-MAG Neuropathy","enrollment":90},{"nctId":"NCT05730816","phase":"PHASE2","title":"MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2023-04-04","conditions":"Mesothelioma","enrollment":130},{"nctId":"NCT03740165","phase":"PHASE3","title":"Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-12-18","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms","enrollment":1367},{"nctId":"NCT07219459","phase":"PHASE2","title":"Visugromab, Nivolumab and a Tyrosine Kinase Inhibitor (TKI) Compared to Double Placebo and a TKI in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure","status":"NOT_YET_RECRUITING","sponsor":"CatalYm GmbH","startDate":"2026-02","conditions":"Unresectable or Metastatic Hepatocellular Carcinoma, Failure of First-Line Treatment That Included an Anti PD-(L)1 Compound, Child-Pugh A Hepatocellular Carcinoma","enrollment":104},{"nctId":"NCT02367040","phase":"PHASE3","title":"Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-08-03","conditions":"Lymphoma,Non-Hodgkin","enrollment":458},{"nctId":"NCT03620136","phase":"PHASE3","title":"Comparison of Two Techniques of Locoregional Analgesia in Total Knee Prosthesis Surgery : Block to the Adductor Channel Versus Peri-articular Local Infiltrations","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2018-02-07","conditions":"Analgesic","enrollment":98},{"nctId":"NCT02982694","phase":"PHASE2","title":"Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer","status":"TERMINATED","sponsor":"Vall d'Hebron Institute of Oncology","startDate":"2017-11-24","conditions":"MSI, ColoRectal Cancer, Chemotherapy","enrollment":46},{"nctId":"NCT02356159","phase":"PHASE1, PHASE2","title":"Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2015-09-24","conditions":"Myelodysplastic Syndromes, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma","enrollment":34},{"nctId":"NCT07195851","phase":"NA","title":"Dermatological Safety and Skin Compatibility Evaluation of Test Products","status":"NOT_YET_RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2025-09","conditions":"Healthy Subjects","enrollment":26},{"nctId":"NCT04291703","phase":"PHASE2","title":"STOP-T1D Low-Dose (ATG)","status":"TERMINATED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2023-11-01","conditions":"Diabetes Mellitus, Type 1","enrollment":2},{"nctId":"NCT05305131","phase":"PHASE2","title":"Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2022-03-28","conditions":"Nasopharyngeal Cancer","enrollment":50},{"nctId":"NCT03461900","phase":"NA","title":"Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock","status":"COMPLETED","sponsor":"University Hospital, Brest","startDate":"2019-06-04","conditions":"Septic Shock","enrollment":535},{"nctId":"NCT07178457","phase":"PHASE3","title":"Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-11-01","conditions":"Cutaneous T Cell Lymphoma (CTCL), Brentuximab Vedotin","enrollment":84},{"nctId":"NCT04794322","phase":"","title":"Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2020-04-13","conditions":"Ovarian Neoplasms, Ovarian Epithelial Carcinoma, Fallopian Tube Neoplasms","enrollment":250},{"nctId":"NCT07176754","phase":"NA","title":"TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2025-10-01","conditions":"Cardiac Arrest (CA), Post Cardiac Arrest Syndrome","enrollment":208},{"nctId":"NCT06830200","phase":"NA","title":"Peri-implantitis Treatment With Chitosan Brush","status":"RECRUITING","sponsor":"Hacettepe University","startDate":"2025-04-10","conditions":"Peri-implantitis","enrollment":60},{"nctId":"NCT03211793","phase":"PHASE1, PHASE2","title":"Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2021-10-06","conditions":"Systemic Sclerosis, Digital Ulcer","enrollment":20},{"nctId":"NCT03970447","phase":"PHASE2, PHASE3","title":"A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma","status":"RECRUITING","sponsor":"Global Coalition for Adaptive Research","startDate":"2019-07-30","conditions":"Glioblastoma","enrollment":1280},{"nctId":"NCT04869397","phase":"PHASE2","title":"Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells","status":"TERMINATED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2021-06-14","conditions":"Covid19","enrollment":19},{"nctId":"NCT06434636","phase":"NA","title":"The Effect of Tranexamic Acid in Endoscopic and Microscopic Ear Surgery Cases on Surgeon Satisfaction","status":"COMPLETED","sponsor":"TC Erciyes University","startDate":"2024-12-01","conditions":"Middle Ear Disease","enrollment":100},{"nctId":"NCT06934473","phase":"NA","title":"Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals","status":"RECRUITING","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2025-05-21","conditions":"Bloodpressure","enrollment":16},{"nctId":"NCT04824092","phase":"PHASE3","title":"Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Incyte Corporation","startDate":"2021-05-11","conditions":"Diffuse Large B-cell Lymphoma","enrollment":899},{"nctId":"NCT03684278","phase":"PHASE2","title":"Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)","status":"RECRUITING","sponsor":"University of Liverpool","startDate":"2019-05-01","conditions":"Acute Pancreatitis","enrollment":290},{"nctId":"NCT07125664","phase":"PHASE2","title":"Intravenous Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study)","status":"NOT_YET_RECRUITING","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2025-10-01","conditions":"Acute Exacerbation Chronic Obstructive Pulmonary Disease","enrollment":36},{"nctId":"NCT06715605","phase":"PHASE2","title":"A Clinical Trial Evaluating the Safety and Efficacy of Myelin-peptide Loaded tolDC as Treatment for MS","status":"WITHDRAWN","sponsor":"University Hospital, Antwerp","startDate":"2025-04-30","conditions":"Multiple Sclerosis","enrollment":""}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"BLOOD LACTIC ACID INCREASED"},{"count":1,"reaction":"CEREBROVASCULAR ACCIDENT"},{"count":1,"reaction":"DYSPNOEA"},{"count":1,"reaction":"ERYTHEMA"},{"count":1,"reaction":"FLUSHING"},{"count":1,"reaction":"HYPERVENTILATION"},{"count":1,"reaction":"LOCAL SWELLING"},{"count":1,"reaction":"PERIPHERAL ISCHAEMIA"},{"count":1,"reaction":"SWELLING FACE"}],"crossReferences":{"chemblId":"CHEMBL2109149"},"_approvalHistory":[],"publicationCount":114,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["normal saline; NaCl 0.9%"],"phase":"marketed","status":"active","brandName":"saline serum","genericName":"saline serum","companyName":"Hédi Chaker Hospital","companyId":"h-di-chaker-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Saline serum is an isotonic sodium chloride solution that restores fluid and electrolyte balance in the body. Used for Fluid and electrolyte replacement in dehydration, Maintenance of vascular volume during surgery or trauma, Vehicle for intravenous medication administration.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:22:41.971744+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}